Uracil-induced replication stress drives mutations, genome instability, anti-cancer treatment efficacy, and resistance
Molecular Cell · 2025-05 · 85 (10) · 1897-1906
DOI: 10.1016/j.molcel.2025.04.015 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Cell, 2025-05. Verfasst von Oliver Mortusewicz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna 171 65, Sweden. Hauptthemen laut MEDLINE: Genomic Instability, DNA Replication, Uracil, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institutet, Vetenskapsrådet, Childhood Cancer Foundation.
Abstract (Originalsprache)
Uracil incorporation into DNA, as a result of nucleotide pool imbalances or cytosine deamination (e.g., through APOBEC3A/3B), can result in replication stress and is the most common source of mutations in cancer and aging. Despite the critical role of uracil in genome instability, cancer development, and cancer therapy, only now is there emerging data on its impact on fundamental processes such as DNA replication and genome stability. Removal of uracil from DNA by base excision repair (BER) can generate a DNA single-strand break (SSB), which can trigger homologous recombination (HR) repair or replication fork collapse and cell death. Unprocessed uracil can also induce replication stress directly and independently of BER by slowing down replication forks, leading to single-stranded DNA (ssDNA) gaps. In this perspective, we review how genomic uracil induces replication stress, the therapeutic implications of targeting uracil-induced vulnerabilities, and potential strategies to exploit these mechanisms in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna 171 65, Sweden.
- Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna 171 65, Sweden. Electronic address: thomas.helleday@scilifelab.se.
Förderung
- Karolinska Institutet
- Vetenskapsrådet
- Childhood Cancer Foundation
- Cancerfonden
- Erling Persson Family Foundation
Zitieren
APA
Mortusewicz, O., Haslam, J., Gad, H., & Helleday, T. (2025). Uracil-induced replication stress drives mutations, genome instability, anti-cancer treatment efficacy, and resistance. Molecular Cell, 85(10), 1897-1906. https://doi.org/10.1016/j.molcel.2025.04.015
Vancouver
Mortusewicz O, Haslam J, Gad H, Helleday T. Uracil-induced replication stress drives mutations, genome instability, anti-cancer treatment efficacy, and resistance. Molecular Cell. 2025;85(10):1897-1906. doi:10.1016/j.molcel.2025.04.015
BibTeX
@article{Mortusewicz2025,
author = {Mortusewicz, Oliver and Haslam, James and Gad, Helge and Helleday, Thomas},
title = {Uracil-induced replication stress drives mutations, genome instability, anti-cancer treatment efficacy, and resistance},
journal = {Molecular Cell},
year = {2025},
volume = {85},
number = {10},
pages = {1897--1906},
doi = {10.1016/j.molcel.2025.04.015}
}
EUVIMED